ICH Q3D / USP <232>/<233> in force since 201824 elements at defined exposure limitsClosed-vessel microwave digestion for USP <233>Liberty 2.0 software — 21 CFR Part 11 compliant
The Regulatory Driver

The most significant change to elemental impurity testing in decades.

ICH Q3D (Guideline for Elemental Impurities) and its pharmacopoeial implementations — USP <232> (Elemental Impurities — Limits) and USP <233> (Elemental Impurities — Procedures) — replaced the century-old wet-chemistry heavy metals test (USP <231>) with instrumental determination of 24 specified elements at defined permitted daily exposure limits, using validated procedures. USP <233> effectively requires ICP-OES or ICP-MS, and specifies closed-vessel microwave digestion for samples that are not readily soluble — in force internationally since 2018 and being implemented by SAHPRA in South Africa.

Applications

Where microwave chemistry sits across the pharma workflow.

Elemental impurity testing

ICH Q3D / USP <232>/<233> — required for all registered medicines. Digestion by MARS 6 or BLADE, followed by ICP-OES or ICP-MS.

Residue & loss on ignition

USP <281> and <733> — routine QC on APIs, excipients and finished products. Phoenix BLACK with sulfated ashing.

Sulfated ash

USP <281> — Phoenix BLACK Sulfated Ashing configuration.

Elemental contaminants in supplements

USP <2232> — similar methodology to pharmaceutical testing. See our Nutraceuticals page.

Microwave synthesis

Medicinal chemistry and API route development — rapid, clean reaction conditions with Discover 2.0.

Peptide APIs

Liberty PRO cGMP synthesiser for GLP-1 and other peptide therapeutics.

Protein digestion

Biopharmaceutical characterisation — digestion workflows including Discover Proteomics.

Extractables & leachables

EDGE solvent extraction from packaging materials.

Peptide API Synthesis

From research-scale route scouting to cGMP peptide manufacture.

The Liberty 2.0 family covers peptide API synthesis from research through cGMP scale, including GLP-1 and other peptide therapeutics. CEM's Liberty PRO is positioned as the cGMP synthesiser for this workflow, with Prodigy 2.0 available for peptide purification.

CEM Liberty peptide synthesiser in laboratory operation
Peptide SynthesisLiberty 2.0 series — the platform underlying research and cGMP peptide API synthesis
The GMP & Qualification Requirement

Instrument qualification is as central to pharma buyers as the chemistry.

South African pharmaceutical manufacturing is regulated by SAHPRA under GMP standards broadly aligned to WHO and ICH guidelines. GMP environments require documented Installation, Operational and Performance Qualification (IQ/OQ/PQ), calibration certificates traceable to NMISA, software validation to 21 CFR Part 11 / EU Annex 11 for electronic records, and documented change control. CEM's Liberty 2.0 software is explicitly 21 CFR Part 11 compliant.

Recommended Products

The pharmaceutical & biotechnology workflow.

ApplicationProduct
Elemental impurity digestion (ICH Q3D / USP <233>)MARS 6, MARSXpress 2.0, BLADE
Residue on ignition / LOIPhoenix BLACK
Sulfated ash (USP <281>, <733>)Phoenix BLACK — Sulfated Ashing
Peptide API synthesis (research)Liberty Blue 2.0, Liberty PRIME 2.0
Peptide API synthesis (cGMP)Liberty PRO
Peptide purificationProdigy 2.0
Microwave synthesis (API route scouting)Discover 2.0
Protein digestion (proteomics / biocharacterisation)Discover Proteomics, DigestPro
Peptide synthesis, entry-level / manual research scaleDiscover Bio
Extractables & leachablesEDGE
Autosampler for ICP analysisASX-series
Trusted By

Laboratories working to GMP and pharmacopoeial standards.

  • · A South African pharmaceutical manufacturer

Named client references appear on this site only where written permission has been given.

Elemental impurities, residue on ignition, or peptide synthesis

Talk to our applications team about ICH Q3D compliance, GMP qualification support, or peptide API synthesis.

Talk to our applications team